CARDIOVASCULAR RNA MARKERS AND ARTIFICIAL INTELLIGENCE MAY IMPROVE COVID-19 OUTCOME : POSITION PAPER FROM THE EU-CardioRNA COST Action CA17129
-
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau)
;
Robinson, Emma L. (Maastricht University) ;
Jusic, Amela (Cardiovascular Research Unit) ;
Carpusca, Irina (Cardiovascular Research Unit) ;
de Windt, Leon J.. (Department of Molecular Genetics) ;
Emanueli, Costanza (National Heart & Lung Institute) ;
Ferdinandy, Péter (Cardiometabolic Research Group and MTA-SE System Pharmacology Research Group) ;
Gu, Wei (Luxembourg Center for Systems Biomedicine) ;
Gyöngyösi, Mariann (Department of Cardiology) ;
Hackl, Matthias (TAmiRNA GmbH) ;
Karaduzovic-Hadziabdic, Kanita (Faculty of Engineering and Natural Sciences) ;
Lustrek, Mitja (Department of Intelligent Systems) ;
Martelli, Fabio (Molecular Cardiology Laboratory) ;
Nham, Eric (University of Zagreb School of Medicine) ;
Potočnjak, Ines (Institute for Clinical Medical Research and Education) ;
Satagopam, Venkata (Luxembourg Center for Systems Biomedicine) ;
Schneider, Reinhard (Luxembourg Center for Systems Biomedicine) ;
Thum, Thomas (Institute of Molecular and Translational Therapeutic Strategies (IMTTS)) ;
Devaux, Yvan (Cardiovascular Research Unit) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
